News
43m
Capital Market on MSNBiocon gets MHRA UK approval for marketing Denosumab biosimilars 'Vevzuo' & 'Evfraxy'Vevzuo is authorized for the prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord ...
Clinical studies have demonstrated that both biosimilars are comparable in safety and efficacy to the reference product, the ...
Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has received ...
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...
Biocon chief Kiran Mazumdar-Shaw has pushed back against Karnataka Chief Minister Siddaramaiah's recent claim that COVID-19 ...
Evfraxy is authorised for the treatment of osteoporosis in men with prostate cancer as increased risk of fractures or ...
Biocon founder Kiran Mazumdar Shaw and Karnataka Chief Minister Siddaramaiah debated on X over the safety of Covid-19 ...
Biocon Biologics gets EU approval for Denosumab biosimilars Vevzuo & Evfraxy, expanding access to bone disease treatments across Europe.
Biocon Biologics delivers 100 million insulin cartridges to Malaysia, commercializes biosimilars in key global markets with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results